201 related articles for article (PubMed ID: 33957979)
1. Large-cell neuroendocrine tumor of the prostate: a case report and review of the literature.
Sleiman W; Karray O; Abi Abdallah M; Bleichner-Perez S; Kourda J; Cosma-Opris M; Assouad S; Riffaud JC; Bart S; Coloby P
J Med Case Rep; 2021 May; 15(1):254. PubMed ID: 33957979
[TBL] [Abstract][Full Text] [Related]
2. Transformation of prostatic adenocarcinoma to well-differentiated neuroendocrine tumor after hormonal treatment.
Gilani S; Guo CC; Li-Ning EM; Pettaway C; Troncoso P
Hum Pathol; 2017 Jun; 64():186-190. PubMed ID: 28159676
[TBL] [Abstract][Full Text] [Related]
3. [Management of neuroendocrine prostate carcinoma: Literature review].
Yossi S; Brahmi T; Enachescu C; Selmaji I; Lapierre A; Samlali H; Chapet O
Cancer Radiother; 2016 Jun; 20(4):330-5. PubMed ID: 27340027
[TBL] [Abstract][Full Text] [Related]
4. Large Cell Neuroendocrine Carcinoma of the Prostate: A Systematic Review and Pooled Analysis.
Tu X; Chang T; Nie L; Qiu S; Xu H; Huang Y; Bao Y; Liu Z; Yang L; Wei Q
Urol Int; 2019; 103(4):383-390. PubMed ID: 30965328
[TBL] [Abstract][Full Text] [Related]
5. Androgen-deprivation therapy in the management of neuroendocrine prostate cancer.
Martínez-Cornelio A; González-Pérez J; Tabares-García Fde J; Ramos-Salgado F; Alvarado-Cabrero I; Hernández-Toriz N
Cir Cir; 2009; 77(4):293-9; 273-8. PubMed ID: 19919791
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
7. Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast.
Cloyd JM; Yang RL; Allison KH; Norton JA; Hernandez-Boussard T; Wapnir IL
Breast Cancer Res Treat; 2014 Dec; 148(3):637-44. PubMed ID: 25399232
[TBL] [Abstract][Full Text] [Related]
8. Primary Prostatic Carcinoma With De Novo Diffuse Neuroendocrine Differentiation.
Galea LA; Mow C; Fine SW; Manohar P
Int J Surg Pathol; 2022 Apr; 30(2):232-236. PubMed ID: 34338584
[TBL] [Abstract][Full Text] [Related]
9. Solitary pulmonary metastasis from prostate cancer with neuroendocrine differentiation: a case report and review of relevant cases from the literature.
Maebayashi T; Abe K; Aizawa T; Sakaguchi M; Ishibash N; Fukushima S; Honma T; Kusumi Y; Matsui T; Kawata N
World J Surg Oncol; 2015 May; 13():173. PubMed ID: 25943541
[TBL] [Abstract][Full Text] [Related]
10. Large-cell neuroendocrine carcinoma of prostate. Case report.
Moratalla Charcos LM; Pastor Navarro T; Cortes Vizcaino V; Osca Garcia JM; Gil Salom M
Arch Esp Urol; 2013 May; 66(4):368-71. PubMed ID: 23676541
[TBL] [Abstract][Full Text] [Related]
11. Primary large cell neuroendocrine carcinoma of the prostate in a hormone naive patient: A case report from Taiwan.
Tzou KY; Cheng WH; Lee WH; Ho CH
J Cancer Res Ther; 2018 Sep; 14(Supplement):S785-S788. PubMed ID: 30249904
[TBL] [Abstract][Full Text] [Related]
12. [Neuroendocrine differentiation in adenocarcinoma of prostate during combined androgen blockade therapy: a case report].
Kitamoto K; Hayashi T; Tamada S; Ezaki K; Kawashima H; Sugimura K; Nakatani T
Hinyokika Kiyo; 2005 Jan; 51(1):33-5. PubMed ID: 15732339
[TBL] [Abstract][Full Text] [Related]
13. Metastatic large-cell neuroendocrine prostate carcinoma: successful treatment with androgen deprivation therapy.
Azad AA; Jones EC; Chi KN
Clin Genitourin Cancer; 2014 Aug; 12(4):e151-3. PubMed ID: 24787970
[No Abstract] [Full Text] [Related]
14. Large cell differentiation of metastatic prostate cancer after androgen deprivation therapy.
Patel R; Faiena I; Geltzeiler J
Can J Urol; 2015 Apr; 22(2):7752-4. PubMed ID: 25891342
[TBL] [Abstract][Full Text] [Related]
15. The Colorful Palette of Neuroendocrine Neoplasms in the Genitourinary Tract.
Pósfai B; Kuthi L; Varga L; Laczó I; Révész J; Kránicz R; Maráz A
Anticancer Res; 2018 Jun; 38(6):3243-3254. PubMed ID: 29848671
[TBL] [Abstract][Full Text] [Related]
16. [Neuroendocrine prostate cancer: Natural history, molecular features, therapeutic management and future directions].
Campedel L; Kossaï M; Blanc-Durand P; Rouprêt M; Seisen T; Compérat E; Spano JP; Malouf G
Bull Cancer; 2017 Sep; 104(9):789-799. PubMed ID: 28673439
[TBL] [Abstract][Full Text] [Related]
17. Long-term control with chemoradiation of initially metastatic mixed adenoneuroendocrine carcinoma of the rectum: a case report.
Semrau S; Agaimy A; Pavel M; Lubgan D; Schmidt D; Cavallaro A; Golcher H; Grützmann R; Fietkau R
J Med Case Rep; 2019 Mar; 13(1):82. PubMed ID: 30902067
[TBL] [Abstract][Full Text] [Related]
18. Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases.
Gurzu S; Kadar Z; Bara T; Bara T; Tamasi A; Azamfirei L; Jung I
World J Gastroenterol; 2015 Jan; 21(4):1329-33. PubMed ID: 25632209
[TBL] [Abstract][Full Text] [Related]
19. "Pure" large cell neuroendocrine carcinoma of the gallbladder. Report of a case and review of the literature.
Buscemi S; Orlando E; Damiano G; Portelli F; Palumbo VD; Valentino A; Marrazzo A; Buscemi G; Lo Monte AI
Int J Surg; 2016 Apr; 28 Suppl 1():S128-32. PubMed ID: 26708705
[TBL] [Abstract][Full Text] [Related]
20. Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer.
Evans AJ; Humphrey PA; Belani J; van der Kwast TH; Srigley JR
Am J Surg Pathol; 2006 Jun; 30(6):684-93. PubMed ID: 16723845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
